General Information of DTT (ID: TT4H1MQ)

DTT Name Neuronal acetylcholine receptor alpha-4 (CHRNA4) DTT Info
Gene Name CHRNA4

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
2 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pentolinium DM38VYQ Hypotension BA20-BA21 Approved [1]
Trimethaphan DMHF4IQ Aneurysm BD51.Z Approved [2]
------------------------------------------------------------------------------------
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
CYTISINE DMUF0BJ Tobacco dependence 6C4A.2 Phase 3 [3]
------------------------------------------------------------------------------------
3 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ABT-418 DMNP72I Alzheimer disease 8A20 Discontinued in Phase 2 [4]
ABT-594 DMGMBCW N. A. N. A. Discontinued in Phase 2 [5]
HOMOEPIBATIDINE DMHP9WV N. A. N. A. Terminated [3]
------------------------------------------------------------------------------------
16 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
(2S,3S)-2-(m-Tolyl)-3,5,5-trimethylmorpholin-2-ol DMDUI8R Discovery agent N.A. Investigative [6]
(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol DMDUGZS Discovery agent N.A. Investigative [6]
3-[2-(N,N,N-trimethylammonium)ethoxy]pyridine DMJB1KL Discovery agent N.A. Investigative [7]
4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one DMM9X0G Discovery agent N.A. Investigative [8]
6'-methylepibatidine DMTG8D0 Discovery agent N.A. Investigative [9]
Barbituric acid derivative DM2I19P Discovery agent N.A. Investigative [10]
BOLDINE DMMVB5P Discovery agent N.A. Investigative [11]
CMI-489 DM4PWDJ Discovery agent N.A. Investigative [9]
N,N-dimethyl(pyridin-3-yl)methanamine DM41C8E Discovery agent N.A. Investigative [12]
N,N-dimethyl-2-(pyridin-3-yloxy)ethanamine DMMD9A0 Discovery agent N.A. Investigative [12]
N,N-dimethyl-4-(pyridin-3-yl)but-3-yn-1-amine DMLX0PI Discovery agent N.A. Investigative [12]
N-ethyl-N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine DMMKSGL Discovery agent N.A. Investigative [12]
N-methyl-2-(pyridin-3-yloxy)ethanamine DMXS43P Discovery agent N.A. Investigative [12]
N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine DMMNIRC Discovery agent N.A. Investigative [12]
N-methyl-N-(pyridin-3-ylmethyl)ethanamine DMOP128 Discovery agent N.A. Investigative [12]
Predicentrine methiodide DM2HN4D Discovery agent N.A. Investigative [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 16 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Nicotinic and nonnicotinic receptor-mediated actions of vinblastine. Proc Soc Exp Biol Med. 1993 Jul;203(3):372-6.
2 Mechanism of long-lasting block of ganglion nicotinic receptors by mono-ammonium compounds with long aliphatic chain. J Auton Nerv Syst. 1994 Aug;48(3):231-40.
3 Epibatidine isomers and analogues: structure-activity relationships. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5493-7.
4 (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization. J Pharmacol Exp Ther. 1994 Jul;270(1):319-28.
5 The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions. Neuroreport. 1999 Dec 16;10(18):3909-13.
6 Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation. J Med Chem. 2010 Jun 24;53(12):4731-48.
7 Aryloxyethylamines: binding at alpha7 nicotinic acetylcholine receptors. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4283-6.
8 Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 rec... J Med Chem. 2010 Sep 9;53(17):6386-97.
9 Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidine. J Med Chem. 2007 Dec 13;50(25):6383-91.
10 Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57.
11 Aporphine metho salts as neuronal nicotinic acetylcholine receptor blockers. Bioorg Med Chem. 2007 May 15;15(10):3368-72.
12 Synthesis and analgesic activity of secondary amine analogues of pyridylmethylamine and positional isomeric analogues of ABT-594. Bioorg Med Chem Lett. 2006 Apr 1;16(7):2013-6.